BMY
Bristol-Myers Squibb CompanyNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$120.03B
P/E Ratio
17.03
EPS
$3.46
Beta
0.27
52W High
$62.89
52W Low
$41.88
50-Day MA
$58.53
200-Day MA
$50.38
Dividend Yield
4.34%
Profit Margin
14.60%
Forward P/E
9.20
PEG Ratio
2.26
About Bristol-Myers Squibb Company
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
Fundamentals
| Revenue (TTM) | $48.19B |
| Gross Profit (TTM) | $35.00B |
| EBITDA | $19.12B |
| Operating Margin | 28.20% |
| Return on Equity | 40.40% |
| Return on Assets | 10.30% |
| Revenue/Share (TTM) | $23.69 |
| Book Value | $9.07 |
| Price-to-Book | 6.34 |
| Price-to-Sales (TTM) | 2.49 |
| EV/Revenue | 3.185 |
| EV/EBITDA | 10.08 |
| Quarterly Earnings Growth (YoY) | 1392.00% |
| Quarterly Revenue Growth (YoY) | 1.30% |
| Shares Outstanding | $2.04B |
| Float | $2.03B |
| % Insiders | 0.10% |
| % Institutions | 83.11% |
Historical Volatility
HV 10-Day
22.61%
HV 20-Day
22.13%
HV 30-Day
20.02%
HV 60-Day
24.26%
HV Rank
7.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($62.72 target)
4
Strong Buy6
Buy18
Hold1
SellData last updated: 3/26/2026